HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancerEric Van Cutsem, Josef Rüschoff, Yung‐Jue Bang et al.|Gastric Cancer|2014Cited by 615
P5-22-01: Feasibility and Patient Safety of Serial Biopsies (bx) in Metastatic HER2−Positive Breast Cancer (BC) To Evaluate Alterations in Molecular Biomarkers (BM): Preliminary Results of SHERsig (Study of HER2 Signature in Metastatic Breast Cancer) a Prospective Phase II Study.Arlene Chan, Ian O. Ellis, Aňa Lluch et al.|Cancer Research|2011Cited by 0